From Laboratory to Market: Shanghai Rural Commercial Bank Empowers Value Co-creation in the High-End Medical Device Industry (Source: FX168)

This article is reposted by Newlife - MIM; all rights reserved by the original author. The original link can be found in the "Sources" section at the end of this article.

To accelerate Shanghai's efforts in building a globally influential hub for the high-end medical device industry, Shanghai Rural Commercial Bank adheres to the philosophy that "planning for sci-tech innovation is planning for the future." The bank has identified high-end medical devices as a key service track, providing full-chain and full-cycle financial services from R&D and technology transfer to mass production. It is committed to promoting the transformation of medical-engineering cross-disciplinary achievements and supporting the comprehensive development of the high-end medical device industry chain.

Among the many sub-sectors of high-end medical equipment, the ultrasonic scalpel has long been monopolized by international brands. Shanghai Ruisu Chuangsheng Medical Technology Co., Ltd. (referred to as "Ruisu Medical"), as one of the first enterprises promoted under the medical-engineering cross-disciplinary sci-tech project of the University of Shanghai for Science and Technology, has broken through core technologies. The R&D team successfully developed an ultrasonic scalpel with independent intellectual property rights. Its unique fishbone structure design achieves continuous blade performance during mass production, and its independently developed tissue-adaptive algorithm not only improves surgical efficiency but also enhances the safety of coagulation and sealing. Crucially, the team developed domestically produced alternative materials, eliminating reliance on expensive foreign raw materials, which both reduced costs and stabilized the supply chain.

However, in the initial stage of transitioning from the laboratory to the market, Ruisu Medical faced practical pressures such as high R&D investment, insufficient revenue, and tight funding. At a joint forum for government, banks, and enterprises, Shanghai Rural Commercial Bank learned of the enterprise's financing needs and promptly conducted due diligence. Relying on the in-depth research and judgment of the medical device industry by the bank's Head Office Industry Research Institute, the bank accurately identified the enterprise's technological barriers and growth potential. Using a forward-looking win-win interest product as an entry point, it customized a comprehensive service plan of "Xinfudai + payroll agency + Xindongneng equity docking empowerment," successfully granting a credit line of 5 million RMB. This effectively alleviated the financial pressure in the early stages of the enterprise's development and accompanied its long-term growth.

This cooperation also provides a beneficial exploration for financial empowerment in the transformation of university achievements. In 2025, Shanghai Rural Commercial Bank launched the "Donation+" service model for the first time, targeting early-stage sci-tech innovation fields such as university achievement transformation. By establishing a special concept verification fund for achievement transformation, the bank promotes the industrialization of scientific research from the laboratory. Currently, this model has been extended to cutting-edge fields such as artificial intelligence, agricultural technology, and brain-computer interfaces.

Like Ruisu Medical and many other sci-tech startups, Shanghai Laina Technology Co., Ltd. (referred to as "Laina Technology"), founded by Zhou Xiangdong's team from Tongji University, also experienced similar "growing pains." Addressing the "choke point" issue where in-situ mass spectrometry ion sources have long relied on imports, Zhou Xiangdong's team developed the Bridge in-situ detection ion source. This is not only a domestic first, but its detection sensitivity also surpasses that of imported equipment. However, as an early-stage sci-tech innovation entity incubated in the park, its core assets are patent technology and the R&D team, making traditional credit models a financing challenge.

Shanghai Rural Commercial Bank evaluated Laina Technology's technological barriers and industrialization prospects with a venture capital mindset, opened a green channel for sci-tech innovation approval, and loaded forward-looking win-win interest products to assist in the industrialization of technological achievements. As a partner bank for the "3310 Talent Plan," the bank also applied for loan interest subsidies for the enterprise, further alleviating financial pressure and releasing research vitality.

Standing at the new starting point of the "15th Five-Year Plan," Shanghai Rural Commercial Bank will continue to build the sci-tech finance 2.0 model driven by the dual wheels of "industry finance + sci-tech innovation ecosystem." It will deeply cultivate frontier industry tracks, deepen the sci-tech finance empowerment ecosystem, guide financial resources to precisely irrigate key industries, and contribute stronger financial power to elevate the construction of the Shanghai (Yangtze River Delta) International Sci-Tech Center to new heights.

Sources

- fx168news.com (2026-09-03) - Original link: From Laboratory to Market: Shanghai Rural Commercial Bank Empowers Value Co-creation in the High-End Medical Device Industry (Source: FX168) - https://fx168news.com/article/1087706